Atripla (efavirenz/emtricitabine/tenofovir disoproxil fumarate) Tablets
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
February 2016
DRUG INTERACTIONS
NS5A inhibitor/NS5B polymerase inhibitor: ledipasvir/sofosbuvir
Patients receiving ATRIPLA and...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts